New Technique for Surgical Epicardial Implantation of a Cardioverter-Defibrillator in Children and Adults With Congenital Heart Disease

被引:9
|
作者
Pospiech, Thomas
Roubertie, Francois
Jalal, Zakaria
Bordachar, Pierre
Thambo, Jean-Benoit
机构
[1] Univ Bordeaux, Bordeaux Heart Univ Hosp, LIRYC, Dept Cardiol,Coronary Unit,Exercise Test & Rehabi, Pessac, France
[2] Univ Bordeaux, Bordeaux Heart Univ Hosp, LIRYC, Dept Pediat & Adult Congenital Heart Dis, Pessac, France
[3] Univ Bordeaux, Bordeaux Heart Univ Hosp, LIRYC, Dept Cardiol,Electrophysiol & Stimulat Unit, Pessac, France
来源
ANNALS OF THORACIC SURGERY | 2016年 / 102卷 / 02期
关键词
EXPERIENCE; PLACEMENT; THERAPY; INFANT; SYSTEM; LEADS;
D O I
10.1016/j.athoracsur.2016.02.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. We assessed a surgical technique for implanting a cardioverter-defibrillator. The indications for cardioverter-defibrillator implantation in pediatric patients and adults with congenital heart disease are relatively specific and require multidisciplinary discussion regarding implantation modalities. We coupled the positioning of two coils sutured to the pericardium with an implantable cardioverter-defibrillator device inserted within a supradiaphragmatic pocket in a population of children and adults with congenital heart disease. Methods. Thirteen consecutive patients, either children or adults with congenital heart disease, underwent the implantation of a single-chamber implantable cardioverter-defibrillator in our center. All patients were systematically followed at 3, 6, and 12 months after implantation. Results. Patients were mainly male (n = 9, 69%), and mean age was 21 +/- 12 years. Median follow-up was 13 months. All patients underwent surgery without acute complication. One patient needed a second surgery because of defibrillation coils fracture. Neither infectious complication nor inappropriate shock was noted. There were two appropriate shocks in 1 patient. Conclusions. This new technique for surgical epicardial implantation of a cardioverter-defibrillator in children and adults with congenital heart disease is safe and feasible. These results should be confirmed by prospective studies with long-term follow-up. (C) 2016 by The Society of Thoracic Surgeons
引用
收藏
页码:615 / 619
页数:5
相关论文
共 50 条
  • [41] HEART-TRANSPLANTATION AFTER CARDIOVERTER-DEFIBRILLATOR IMPLANTATION - A CASE-CONTROL STUDY
    NOVICK, RJ
    MENKIS, AH
    GUIRAUDON, GM
    SANDLER, D
    PFLUGFELDER, PW
    KOSTUK, WJ
    YEE, R
    KLEIN, GJ
    POWELL, AM
    MCKENZIE, FN
    CHEST, 1993, 103 (06) : 1710 - 1714
  • [42] Prophylactic Implantation of Implantable Cardioverter-Defibrillator for Japanese Patients With Heart Failure - Problem of "Underuse"
    Kuga, Keisuke
    CIRCULATION JOURNAL, 2015, 79 (02) : 297 - 299
  • [43] Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping
    Zeb, Mehmood
    Curzen, Nicholas
    Veldtman, Gruschen
    Yue, Arthur
    Roberts, Paul
    Wilson, David
    Morgan, John
    EUROPACE, 2015, 17 (07): : 1059 - 1067
  • [44] A NEW TRANSVENOUS INTERNAL CARDIOVERTER-DEFIBRILLATOR - IMPLANTATION TECHNIQUE, COMPLICATIONS, AND SHORT-TERM FOLLOW-UP
    JORDAENS, L
    VERTONGEN, P
    PROVENIER, F
    TROUERBACH, JW
    POELAERT, J
    HERREGODS, L
    AMERICAN HEART JOURNAL, 1995, 129 (02) : 251 - 258
  • [45] Lesion-Specific Differences for Implantable Cardioverter Defibrillator Therapies in Adults with Congenital Heart Disease
    Kella, Danesh K.
    Merchant, Faisal M.
    Veledar, Emir
    Book, Wendy
    Lloyd, Michael S.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2014, 37 (11): : 1492 - 1498
  • [46] Totally Subcutaneous Implantable Cardioverter-defibrillator in a Child With Complex Congenital Heart Disease and Infection in a Previous Transvenous System
    Garcia-Riesco, Lorena
    Pedrote, Alonso
    Arana-Rueda, Eduardo
    Adsuar, Alejandro
    Arce-Leon, Alvaro
    Guerrero-Marquez, Francisco
    REVISTA ESPANOLA DE CARDIOLOGIA, 2014, 67 (11): : 961 - 962
  • [47] Outcome of implantable cardioverter defibrillator therapy for congenital heart disease
    Uyeda, Tomomi
    Inoue, Kanki
    Sato, Junichiro
    Mizukami, Ayumi
    Yoshikawa, Tadahiro
    Wada, Naoki
    Ando, Makoto
    Takahashi, Yukihiro
    Umemura, Jun
    Park, In-Sam
    PEDIATRICS INTERNATIONAL, 2012, 54 (03) : 379 - 382
  • [48] PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design
    J. T. Vehmeijer
    Z. Koyak
    A. H. Zwinderman
    L. Harris
    R. Peinado
    E. N. Oechslin
    C. K. Silversides
    B. J. Bouma
    W. Budts
    I. C. van Gelder
    J. M. Oliver
    B. J. M. Mulder
    J. R. de Groot
    Netherlands Heart Journal, 2019, 27 : 474 - 479
  • [49] RISK FACTORS FOR IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR LEAD FAILURE IN CHILDREN AND YOUNG ADULTS
    Janson, Christopher M.
    Patel, Akash
    Shah, Maully
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E283 - E283
  • [50] The validity of current implantable cardioverter-defibrillator guidelines in a real-world population of adults with congenital heart disease: A single-center experience
    Kawada, Satoshi
    Chakraborty, Praloy
    Nanthakumar, Jared
    Albertini, Lisa
    Oechslin, Erwin N.
    Roche, Susan Lucy
    Silversides, Candice
    Wald, Rachel M.
    Downar, Eugene
    Harris, Louise
    Swan, Lorna
    Alonso-Gonzalez, Rafael
    Thorne, Sara
    Nanthakumar, Kumaraswamy
    Mondesert, Blandine
    Khairy, Paul
    Nair, Krishnakumar
    INTERNATIONAL JOURNAL OF CARDIOLOGY CONGENITAL HEART DISEASE, 2022, 8